TCGA-Assembler 2
TCGA-Assembler 2 retrieves, processes, and integrates cancer genomics data from The Cancer Genome Atlas (TCGA) via the Genomic Data Commons (GDC) and proteomics data from the Clinical Proteomic Tumor Analysis Consortium (CPTAC) to enable integrated multi-omic analyses of cancer.
Key Features:
- Automated Data Retrieval: Automates downloading of genomic datasets from GDC and proteomic datasets from CPTAC.
- Data Integration: Integrates diverse genomics and proteomics datasets into combined data structures for joint analysis.
- Enhanced Data Handling and Processing: Implements improvements in data handling and processing performance for large-scale cancer datasets.
- Reproducibility: Provides a standardized approach for data retrieval and integration that supports reproducible multi-omic analyses.
Scientific Applications:
- Multi-omic integration: Enables combined analysis of genomics and proteomics to study complex molecular relationships in cancer.
- Genotype–phenotype relationships: Facilitates exploration of interactions between genetic mutations and protein expression across tumors.
- Biomarker discovery: Supports identification of candidate biomarkers by correlating genomic alterations with proteomic measurements.
- Therapeutic target identification and mechanism studies: Assists identification of potential therapeutic targets and investigation of disease mechanisms using integrated datasets.
Methodology:
The software uses algorithms to automate data retrieval from GDC and CPTAC, followed by a processing pipeline that integrates the retrieved datasets into a unified format.
Topics
Collections
Details
- License:
- GPL-3.0
- Tool Type:
- command-line tool
- Operating Systems:
- Linux, Windows, Mac
- Added:
- 6/26/2018
- Last Updated:
- 11/25/2024
Operations
Publications
Wei L, Jin Z, Yang S, Xu Y, Zhu Y, Ji Y. TCGA-assembler 2: software pipeline for retrieval and processing of TCGA/CPTAC data. Bioinformatics. 2017;34(9):1615-1617. doi:10.1093/bioinformatics/btx812. PMID:29272348. PMCID:PMC5925773.